Effects of ouabain on NIH/3T3 cells transformed with retroviral oncogenes and on human tumor cell lines.
Both murine and human cell lines transformed by the v-Ki-ras gene have been shown to be much more sensitive to the toxic effects of the cardiac glycoside ouabain than their respective controls. This differential toxicity has previously been used in the isolation of flat revertant clones from populations of Kirsten murine sarcoma virus transformed NIH/3T3 cells. Here, we have undertaken a further characterization of this phenomenon in murine and human tumor cells. Two different techniques, a 51Cr-release assay and a quantitative Crystal violet elution assay, have been employed to compare the sensitivities to ouabain of normal and v-Ki-ras-transformed NIH/3T3 cells. In each assay, ras-transformed NIH/3T3 cell lines displayed an increased sensitivity to ouabain as compared to the parental NIH/3T3 cell line, both in dose-response and in time-course experiments. In a separate study, ouabain was also able to inhibit the growth in semi-solid medium of 2 v-Ki-ras-transformed NIH/3T3 cell lines (DT and K-NIH) in a dose-dependent fashion. The same concentrations of ouabain were effective in both the 51Cr-release and Crystal violet assays. To address the question of whether increased sensitivity to ouabain is a specific result of transformation with the ras oncogene or is a common event which accompanies transformation by other oncogenes, we have screened a variety of transformed NIH/3T3 derivatives. All of these lines displayed an increased sensitivity to ouabain when compared to the parental NIH/3T3 cell line.
Tagliaferri
P
P
Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD 20892.
Yanagihara
K
K
Ciardiello
F
F
Talbot
N
N
Flatow
U
U
Benade
L
L
Bassin
R H
RH
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002860:Chromium Radioisotopes; D003110:Colonic Neoplasms; D004353:Drug Evaluation, Preclinical; D005840:Gentian Violet; D006801:Humans; D010042:Ouabain / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014412:Tumor Virus Infections
D002860:Chromium Radioisotopes; D010042:Ouabain; D005840:Gentian Violet